Avalere Health Insights Who We Help Expertise About Us Submit Connect Real-World Data Widespread availability of real-world data has enabled the generation of evidence and insights that benefit patients, providers, plans, and industry. Explore our real-world data analyses to support your strategic decisions. Featured Content Real-World Data Utilization Management Trends in the Commercial Market, 2014–2020 The Pharmaceutical Research and Manufacturers of America (PhRMA) commissioned Avalere to examine the... Tiernan Meyer Real-World Data Digital Health Advances Create Opportunities for Access and Engagement Digital health solutions continue to advance the way healthcare is delivered. Through research and d... Brigit Kyei-Baffour Real-World Data Rare and Orphan Disease Therapies Require New Distribution Strategies Manufacturers currently in the developmental phase for drug assets targeting rare or orphan diseases... Kevin Kissling Sort by Topic 2020 Election Alternative Payment Models COVID-19 Intel Center Drug Pricing FDA Regulatory Pathways Federal Policy Healthcare Industry Outlook Quality Improvement Real-World Data Social Determinants of Health State Policy Vaccines / Preventive Services Value Assessments Value-Based Care November 24, 2021 Real-World Data Utilization Management Trends in the Commercial Market, 2014–2020 The Pharmaceutical Research and Manufacturers of America (PhRMA) commissioned Avalere to examine the prevalence of utilization management (UM) over time in the commercial market, which includes employer-sponsored health plans and the health insurance exchanges. Tiernan Meyer Rebecca Yip Yonatan Mengesha Daymelis Santiesteban Richard Hamilton June 10, 2021 Real-World Data Digital Health Advances Create Opportunities for Access and Engagement Digital health solutions continue to advance the way healthcare is delivered. Through research and development as well as stakeholder partnerships, life science companies can leverage digital health technologies to optimize access along the patient care journey. Brigit Kyei-Baffour Sloan Tandet Dana Macher Richard Prest May 18, 2021 Real-World Data Rare and Orphan Disease Therapies Require New Distribution Strategies Manufacturers currently in the developmental phase for drug assets targeting rare or orphan diseases should assess the commercialization implications when bringing novel therapies to market and how they may differ from the standard pharmaceutical supply chain and economics. Kevin Kissling Richard Prest Elizabet Shvets James Coffelt Omar Hafez April 27, 2021 Real-World Data AI in Healthcare: Raise the Evidence Bar Now or Be Forced to Later In 2012, experts predicted that artificial Intelligence (AI) would eventually replace as much as 80% of current clinical practice by physicians. While AI has certainly expanded in healthcare—especially during the COVID-19 pandemic—the last few years have included some eventful setbacks in the use of AI across several sectors of the economy, including healthcare. Joe Lynch March 31, 2021 Real-World Data Inovalon Data Powers New Insights on Diverse Healthcare Populations Data-Driven Research Presented at Academy of Managed Care Pharmacy (AMCP), ISPOR Annual Meeting and Key Spring Conferences Powered by Inovalon’s MORE2 Registry® Dataset John E. Linnehan February 12, 2021 Real-World Data Podcast: Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma Tune into our first episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, our experts discuss recent research that, using Medicare fee-for-service claims data, studied healthcare utilization, costs, outcomes, and other characteristics of patients who received CAR T-cell therapy for large B-cell lymphoma. Karl Kilgore Amy Schroeder February 12, 2021 Real-World Data Video: Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma Tune into our first episode in the Avalere Health Essential Voice series focused on disease education. In this segment, our experts discuss recent research that, using Medicare fee-for-service claims data, studied healthcare utilization, costs, outcomes, and other characteristics of patients who received CAR T-cell therapy for large B-cell lymphoma. Karl Kilgore Amy Schroeder January 15, 2021 Real-World Data IoT: Opportunities and Use Cases for Life Sciences Organizations Internet of Things (IoT) is a catch-all term that refers to any device that can connect to a network (including the Internet) and communicate with other devices. Prosper Igboeli Kristi Mitchell Oladeji Faborode November 4, 2020 Real-World Data A Data-Driven Approach to Identifying Patients with AAD On November 4, Avalere experts presented “Development of a Claims-Based Algorithm to Identify Patients with Agitation in Alzheimer’s Dementia” at the Gerontological Society of America Annual Scientific Meeting. Christie Teigland Zul Pulungan August 27, 2020 Real-World Data Podcast: CMS and ONC Interoperability and Patient Access Mandates, Part 2 Tune into another episode of Start Your Day with Avalere. In this segment, health plan experts delve into the strategic opportunities the federal government’s interoperability requirements present and consider which mandates might be coming down the pike. Fred Bentley August 19, 2020 Real-World Data Podcast: CMS and ONC Interoperability and Patient Access Mandates, Part 1 Tune into another episode of Start Your Day with Avalere. In this segment, health plan experts delve into the federal government’s interoperability requirements and how plans are navigating these changes. Fred Bentley June 23, 2020 Real-World Data New Data Approaches for Novel Curative Therapies and APMs On June 9, Avalere experts discussed new data analytics and approaches for evaluating value-based topics in healthcare in the “New Data Approaches for Novel Curative Therapies & APMs” webinar. They examined the current approaches to assessing the value of treatments, novel curative therapy affordability and access, and the role of data in healthcare decision-making. John C. Neal Brian Leinwand John Feore Mali Khan Real-World Data Webinar: New Data Analytics Approaches for Novel Curative Therapies & APMs Avalere experts discussed new data analytics and health economics and outcomes research approaches for evaluating key value-based topics in healthcare, including novel curative therapy affordability and access, alternative payment models, and the increasingly important role of real-world evidence in healthcare decision-making. Christie Teigland John Feore Brian Leinwand John C. Neal May 7, 2020 Real-World Data The Burden and Costs of Recurrent Clostridioides Difficile Recurring episodes of clostridioides difficile (c diff) create significant added healthcare burden and costs to society and lead to avoidable adverse outcomes in the Medicare population Christie Teigland Alexis Parente March 17, 2020 Real-World Data Avalere Health Partners with Leading Registry and Analytics Company, Corrona LLC, to Combine Economic and Clinical Outcomes Data for Autoimmune Diseases The collaboration leverages the Inovalon MORE2 Registry® payer-sourced dataset and Corrona’s platform of clinical registries to enable data-driven insights on the treatment of autoimmune diseases from both clinical and health economic perspectives. John E. Linnehan March 4, 2020 Real-World Data Chronic Disease Mobile Health Apps Need Better Value Propositions and Evidence Rising healthcare costs and the increased prevalence of chronic disease in the US are incentivizing stakeholders to develop new solutions to tackle these issues. Many have turned to digital health innovations like mobile health applications to facilitate care prevention and management for chronic disease, but significant gaps remain in their ability to be used in real-world practice. Emily Belowich Jasmaine McClain March 3, 2020 Real-World Data Patient Registries Can Pave the Way to Establishing a Learning Health System As the shape and scope of America’s learning health system evolves, Avalere partners with industry leaders, engaging multiple stakeholders to formulate patient registry strategies that develop, evaluate, and utilize registry data – and help improve care in real time. Kristi Mitchell February 19, 2020 Real-World Data Medication Adherence Rates Low Among Patients with Serious Mental Illness Avalere research recently published in ClinicoEconomics and Outcomes Research compared patient characteristics and real-world outcomes in 2 distinct high-risk cohorts of patients with serious mental illness (SMI), including patients with a hospitalization related to SMI (recently discharged) and patients newly diagnosed with SMI (early episode). The research included 51,705 patients with bipolar disorder, major depressive disorder, and schizophrenia. Christie Teigland Seung Kim January 21, 2020 Real-World Data Digital Health 2020: 4 Tactics for Successful Collaboration Digital health remains a powerful focal point in the push towards value-based healthcare. Across multiple domains, emerging technologies provide promising strategies for delivering more effective, efficient, and personalized care. Jasmaine McClain December 16, 2019 Real-World Data AI in Healthcare: 5 Areas in Which Artificial Intelligence Is Disrupting the Status Quo The rapid expansion of artificial intelligence (AI) across healthcare holds the promise of dramatically altering not only diagnosis and treatment but also research, risk assessment, drug development, care management, and even insurance and payment systems. Christina Badaracco Page 1 Page 2 Page 3 Next Avalere Health An Inovalon Company 1201 New York Avenue NW Suite 1000 Washington, DC 20005 Phone 202.207.1300 Fax 202.467.4455 info@avalere.com Contact Careers Privacy Policy Terms of Use Twitter LinkedIn Avalere is a healthcare consulting firm dedicated to improving healthcare. Our life sciences, plan, and provider clients count on us to help them anticipate and adapt to the latest industry trends. © 2021 - Avalere Health We'll assume you're ok with this, but you can opt-out if you wish.Accept